XML 74 R67.htm IDEA: XBRL DOCUMENT v3.25.2
Stock Based Compensation - Summary of Non-vested Stock Options Outstanding (Detail) - USD ($)
$ / shares in Units, $ in Thousands
 6 Months Ended 12 Months Ended
Jun. 30, 2025
Dec. 31, 2024
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]      
Stock options at beginning of year 519,644 249,144  
Number of Shares Granted 249,144 280,500  
Number of Shares Forfeited (2,750) (10,000)  
Stock options at end of year 516,894 519,644 249,144
Fully vested and expected to vest 159,430 79,715  
Exercisable at end of year 159,430 79,715  
Weighted Average Exercise Price Outstanding at beginning of year $ 8.72 $ 8.06  
Weighted Average Exercise Price Granted 8.06 9.29  
Weighted Average Exercise Price Forfeited 9.29 8.06  
Weighted Average Exercise Price Outstanding at Ending of year 8.72 8.72 $ 8.06
Weighted Average Exercise Price Fully vested and expected to vest 8.06 8.06  
Weighted Average Exercise Price Exercisable at end of year $ 8.06 $ 8.06  
Weighted Average Remaining Contractual Term 8 years 3 months 18 days 8 years 10 months 24 days 9 years 4 months 24 days
Weighted Average Remaining Contractual Term Fully vested and expected to vest 7 years 9 months 18 days 8 years 4 months 24 days  
Weighted Average Remaining Contractual Term Exercisable at end of year 7 years 9 months 18 days 8 years 4 months 24 days  
Aggregate Intrinsic Value Outstanding $ 1,380 $ 684  
Aggregate Intrinsic Value Fully vested and expected to vest 531 158  
Aggregate Intrinsic Value Exercisable at end of year $ 531 $ 158  
Date of grant May 25, 2023 Dec. 02, 2024  
Vesting period 3 years 3 years  
Expiration date May 25, 2033 Dec. 02, 2034  
Expected volatility 27.80% 31.50%  
Expected term 6 years 6 months 6 years 6 months  
Expected dividend yield 0.00% 0.00%  
Expected forfeiture rate 0.00% 0.00%  
Risk free interest rate 3.90% 4.10%  
Fair value per option $ 3 $ 3.78